S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NYSE:BAX

Baxter International (BAX) Stock Forecast, Price & News

$73.23
+0.63 (+0.87%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$72.07
$73.30
50-Day Range
$70.53
$80.00
52-Week Range
$69.71
$89.70
Volume
1.70 million shs
Average Volume
3.45 million shs
Market Capitalization
$36.87 billion
P/E Ratio
35.04
Dividend Yield
1.54%
Beta
0.62
30 days | 90 days | 365 days | Advanced Chart
Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

Baxter International logo

About Baxter International

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
60,000
Year Founded
1931

Sales & Book Value

Annual Sales
$12.78 billion
Cash Flow
$5.49 per share
Book Value
$18.11 per share

Profitability

Net Income
$1.28 billion
Pretax Margin
9.01%

Debt

Price-To-Earnings

Miscellaneous

Free Float
502,472,000
Market Cap
$36.87 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/1 Dividend
2/24/2022
Dividend Payable
4/01/2022
Last Earnings
4/28/2022
Today
5/22/2022
Ex-Dividend for 7/1 Dividend
6/02/2022
Dividend Payable
7/01/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

3.15 out of 5 stars

Medical Sector

7th out of 1,416 stocks

Surgical & Medical Instruments Industry

2nd out of 138 stocks

Analyst Opinion: 3.4Community Rank: 4.7Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -













Baxter International (NYSE:BAX) Frequently Asked Questions

Is Baxter International a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 1 sell rating, 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International
or view top-rated stocks.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 7,200,000 shares, an increase of 31.1% from the April 15th total of 5,490,000 shares. Based on an average trading volume of 3,560,000 shares, the short-interest ratio is currently 2.0 days. Approximately 1.4% of the shares of the company are short sold.
View Baxter International's Short Interest
.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Baxter International
.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) issued its quarterly earnings results on Thursday, April, 28th. The medical instruments supplier reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.13. The medical instruments supplier earned $3.71 billion during the quarter, compared to the consensus estimate of $3.68 billion. Baxter International had a trailing twelve-month return on equity of 21.59% and a net margin of 7.80%. The company's revenue for the quarter was up 25.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.76 EPS.
View Baxter International's earnings history
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, May 3rd. Stockholders of record on Friday, June 3rd will be paid a dividend of $0.29 per share on Friday, July 1st. This represents a $1.16 annualized dividend and a yield of 1.58%. The ex-dividend date is Thursday, June 2nd. This is a positive change from Baxter International's previous quarterly dividend of $0.28.
View Baxter International's dividend history
.

Is Baxter International a good dividend stock?

Baxter International pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.54%. Baxter International has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 53.59%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 23.33% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $4.12-$4.20 for the period, compared to the consensus earnings per share estimate of $4.29. The company issued revenue guidance of $15.72 billion-$15.85 billion, compared to the consensus revenue estimate of $15.90 billion.

What price target have analysts set for BAX?

14 Wall Street analysts have issued twelve-month price objectives for Baxter International's shares. Their forecasts range from $77.00 to $105.00. On average, they anticipate Baxter International's share price to reach $91.83 in the next year. This suggests a possible upside of 25.4% from the stock's current price.
View analysts' price targets for Baxter International
or view top-rated stocks among Wall Street analysts.

Who are Baxter International's key executives?
Baxter International's management team includes the following people:
  • Mr. Jose E. Almeida, Chairman, Pres & CEO (Age 60, Pay $3.72M)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 49, Pay $1.62M)
  • Mr. Giuseppe Accogli, Exec. VP & COO (Age 51, Pay $1.78M) (LinkedIn Profile)
  • Mr. Andrew Frye, Sr. VP & Pres of APAC (Age 57, Pay $1.68M) (LinkedIn Profile)
  • Mr. Cristiano Franzi, Sr. VP & Pres for EMEA (Age 59, Pay $1.76M)
  • Mr. Brian C. Stevens, Sr. VP, Chief Accounting Officer & Controller (Age 47) (LinkedIn Profile)
  • Mr. Talvis P. Love, Sr. VP & Chief Information Officer (Age 54)
  • Ms. Clare Trachtman, VP of Investor Relations
  • Mr. David S. Rosenbloom, Sr. VP & Gen. Counsel
  • Ms. Stacey Eisen, Sr. VP of Global Communications
What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), (HON), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Bank of New York Mellon Corp (0.83%), Caisse DE Depot ET Placement DU Quebec (0.76%), California Public Employees Retirement System (0.74%), New York State Common Retirement Fund (0.46%), Sumitomo Mitsui Trust Holdings Inc. (0.30%) and Eagle Asset Management Inc. (0.22%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, James R Gavin III and John D Forsyth.
View institutional ownership trends for Baxter International
.

Which institutional investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Brown Brothers Harriman & Co., Caisse DE Depot ET Placement DU Quebec, Jarislowsky Fraser Ltd, New York State Common Retirement Fund, State of Tennessee Treasury Department, Bank of New York Mellon Corp, Simplex Trading LLC, and California Public Employees Retirement System. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, and Brian Stevens.
View insider buying and selling activity for Baxter International
or view top insider-selling stocks.

Which institutional investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including Tobam, BNP Paribas Arbitrage SA, Cooke & Bieler LP, Russell Investments Group Ltd., Nisa Investment Advisors LLC, Eagle Asset Management Inc., Quantbot Technologies LP, and Jane Street Group LLC.
View insider buying and selling activity for Baxter International
or or view top insider-buying stocks.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $73.23.

How much money does Baxter International make?

Baxter International has a market capitalization of $36.87 billion and generates $12.78 billion in revenue each year. The medical instruments supplier earns $1.28 billion in net income (profit) each year or $2.089990 on an earnings per share basis.

How many employees does Baxter International have?

Baxter International employs 60,000 workers across the globe.

Does Baxter International have any subsidiaries?

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..

When was Baxter International founded?

Baxter International was founded in 1931.

What is Baxter International's official website?

The official website for Baxter International is www.baxter.com.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at [email protected], or via fax at 224-948-1813.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.